ストックスクリーナーアプリを入手
3.41
4.92%
0.16
前日終値:
$3.25
開ける：
$3.3
24時間の取引高:
40,128
Relative Volume:
0.61
時価総額：
$100.60M
収益：
$4.01M
当期純損益:
$-35.01M
株価収益率:
-2.9397
EPS:
-1.16
ネットキャッシュフロー:
$-24.53M
1週間 パフォーマンス:
-5.54%
1か月 パフォーマンス:
-22.85%
6か月 パフォーマンス:
-45.09%
1年 パフォーマンス:
-37.66%
1日の値動き範囲:
$3.27
$3.47
1週間の範囲:
$3.22
$3.69
52週間の値動き範囲:
$3.22
$9.96
Xbiotech Inc Stock (XBIT) Company Profile
XBIT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
3.41 | 100.60M | 4.01M | -35.01M | -24.53M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.58 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.96 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
669.02 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.13 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.53 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-06-14 | 開始されました | Piper Jaffray | Overweight |
| 2017-04-21 | ダウングレード | Noble Financial | Buy → Hold |
| 2016-06-28 | 繰り返されました | Noble Financial | Buy |
Xbiotech Inc (XBIT) 最新ニュース
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider
Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider
XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - Markets Insider
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider
Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World
Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.
XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance
Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire
State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World
XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks
Franklin Resources Inc. Trims Stock Holdings in JD.com, Inc. (NASDAQ:JD) - Defense World
XBiotech (NASDAQ:XBIT) Has Debt But No Earnings; Should You Worry? - Simply Wall St
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kzKSPI - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire
XBiotech halts all rheumatology research after missing Phase II endpoints - Yahoo Finance
Stock market news: YSX Tech. -28.67%, XBiotech -24.76% among biggest losers during mid day trading - Business Upturn
Another bump in the road for XBiotech and bermekimab - The Pharma Letter
Xbiotech Shares Hit 52-Week Low on Halted Rheumatology Program - MarketWatch
XBiotech Stock Hits 52-Week Low at $3.75 Amid Market Fluctuations - Investing.com
Stock market today: XBiotech -31.66%, Nvni Group -31.59% among biggest losers in early trading - Business Upturn
XBiotech trading resumes - Nasdaq
XBiotech Halts Rheumatology Clinical Program - MarketWatch
XBiotech Pauses Rheumatology program - GlobeNewswire
XBiotech Halts Rheumatology Program After Major Data Irregularities Found in Phase 2 Trial - StockTitan
Fmr LLC Has $224,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World
(XBIT) Proactive Strategies - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
12,157 Shares in XBiotech Inc. (NASDAQ:XBIT) Purchased by MetLife Investment Management LLC - Defense World
XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World
(XBIT) Investment Analysis and Advice - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Trend Tracker for (XBIT) - Stock Traders Daily
Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR
How To Trade (XBIT) - Stock Traders Daily
XBiotech: Q3 Earnings Snapshot - New Haven Register
Xbiotech Inc (XBIT) 財務データ
収益
当期純利益
現金流量
EPS
0.56%
1.50%
大文字化:
|
ボリューム (24 時間):